Gilead’s Yescarta edges ahead of Kymriah in CAR-T race
Second quarter financials revealed that Gilead’s Yescarta has achieved double the sales of rival CAR-T treatment, Novartis’ Kymriah.
Archives for July 31, 2019
Bayer recalls mislabeled vials of hemophilia treatment
Bayer recalls vials of an antihemophilic treatment after the discovery that nearly 1,000 were mislabeled with a therapy indicated for an adult patient population.
Medicxi raises €400m in latest fund to support EU biotech
Medicxi announces the closure of its third fund, which generated €400m to be used in the development of early- and late-stage European biotechs.